Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Quantum Biopharma Ltd. (QNTM) had Debt to Equity Ratio of 0.27 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-8.74M |
|
-- |
|
-- |
|
$3.40M |
|
$-3.40M |
|
$-5.34M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-3.40M |
|
$-3.27M |
|
2.48M |
|
2.48M |
|
$-3.53 |
|
$-3.53 |
|
| Balance Sheet Financials | |
$9.93M |
|
$0.07M |
|
$4.94M |
|
$14.87M |
|
$10.34M |
|
-- |
|
-- |
|
$10.34M |
|
$4.53M |
|
$-0.30M |
|
$4.53M |
|
2.71M |
|
| Cash Flow Statement Financials | |
$-4.26M |
|
$-1.35M |
|
$3.13M |
|
$6.00M |
|
$3.52M |
|
$-2.48M |
|
$0.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.96 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.27 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-192.97% |
|
2903.24% |
|
-58.76% |
|
-192.97% |
|
$1.67 |
|
$-1.72 |
|
$-1.72 |
|